Clinical Trial Update: Mode of Action of Moviprep [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating the mode of action of Moviprep in functional constipation and IBS with constipation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Constipation
• Irritable Bowel Syndrome with Constipation

Drugs mentioned

• MoviPrep

Snippet

Sponsor: University of Nottingham | Conditions: Functional Constipation, Irritable Bowel Syndrome Characterized by Constipation | Phase 4 | Status: COMPLETED